Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer

D. James, Nicholas; Spears, Melissa; W. Clarke, Noel; P. Dearnaley, David; D. Mason, Malcolm; Parker, Christopher; Ritchie, A.W.S.; M. Russell, John; Schiavone, Francesca; Attard, Gerhardt; S. de Bono, Johann; Birtle, Alison; Engeler, Daniel; Elliott, Tony; Matheson, David; M. O’Sullivan, Joe; Pudney, Delia; Srihari, Narayanan; Wallace, Jan; Barber, Jim; Syndikus, Isabel; Parmar, Mahesh; R. Sydes, Matthew; the STAMPEDE Investigators, for

doi:10.1001/jamaoncol.2015.4350

Public

Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer

Published in JAMA Oncology • Nov 25, 2015

Authors:

Nicholas D. James

Melissa Spears

Noel W. Clarke

Abstract

IMPORTANCE: The natural history of patients with newly diagnosed high-risk nonmetastatic (M0) prostate cancer receiving hormone therapy (HT) either alone or with standard-of-care radiotherapy (RT) is not well documented. Furthermore, no clinical trial has assessed the role of RT in patients with nod...

Subject

Medicine

Prostate cancer

Radiation therapy

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!